Bio-Rad Laboratories (BIO) Debt to Equity (2016 - 2025)
Historic Debt to Equity for Bio-Rad Laboratories (BIO) over the last 17 years, with Q4 2025 value amounting to $0.16.
- Bio-Rad Laboratories' Debt to Equity fell 1176.86% to $0.16 in Q4 2025 from the same period last year, while for Dec 2025 it was $0.16, marking a year-over-year decrease of 1176.86%. This contributed to the annual value of $0.16 for FY2025, which is 1176.86% down from last year.
- Latest data reveals that Bio-Rad Laboratories reported Debt to Equity of $0.16 as of Q4 2025, which was down 1176.86% from $0.18 recorded in Q3 2025.
- In the past 5 years, Bio-Rad Laboratories' Debt to Equity ranged from a high of $0.18 in Q4 2024 and a low of $0.0 during Q3 2021
- Over the past 5 years, Bio-Rad Laboratories' median Debt to Equity value was $0.14 (recorded in 2022), while the average stood at $0.12.
- Per our database at Business Quant, Bio-Rad Laboratories' Debt to Equity tumbled by 4994.57% in 2021 and then surged by 2024233.15% in 2022.
- Bio-Rad Laboratories' Debt to Equity (Quarter) stood at $0.0 in 2021, then skyrocketed by 16113.61% to $0.12 in 2022, then increased by 10.13% to $0.14 in 2023, then surged by 33.21% to $0.18 in 2024, then fell by 11.77% to $0.16 in 2025.
- Its Debt to Equity stands at $0.16 for Q4 2025, versus $0.18 for Q3 2025 and $0.17 for Q2 2025.